Home Tags DREAMM trials

Tag: DREAMM trials

Belantamab Mafodotin Receives Priority Review for Relapsed or Refractory Multiple Myeloma

The United States Food and Drug Administration (FDA) has granted a priority review of a Biologics License Application (BLA) for belantamab mafodotin (GSK2857916), a...